Citigroup Inc Fulgent Genetics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 33,092 shares of FLGT stock, worth $583,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,092

Previous 22,856 44.78%

Holding current value

$583,411

Previous $448,000 60.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.6 - $25.06 $200,625 - $256,514	10,236 Added 44.78%	33,092 $718,000
Q2 2024 Aug 12, 2024	BUY	$19.09 - $22.57 $41,482 - $49,044	2,173 Added 10.51%	22,856 $448,000
Q1 2024 May 10, 2024	BUY	$21.55 - $29.29 $138,049 - $187,631	6,406 Added 44.87%	20,683 $448,000
Q4 2023 Feb 09, 2024	BUY	$23.64 - $30.27 $112,029 - $143,449	4,739 Added 49.69%	14,277 $412,000
Q3 2023 Nov 09, 2023	SELL	$26.74 - $40.81 $171,617 - $261,918	-6,418 Reduced 40.22%	9,538 $255,000
Q2 2023 Aug 10, 2023	BUY	$28.52 - $40.7 $145,537 - $207,692	5,103 Added 47.02%	15,956 $590,000
Q1 2023 May 11, 2023	SELL	$29.39 - $36.27 $142,717 - $176,127	-4,856 Reduced 30.91%	10,853 $338,000
Q4 2022 Feb 09, 2023	BUY	$29.23 - $40.28 $141,677 - $195,237	4,847 Added 44.62%	15,709 $467,000
Q3 2022 Nov 10, 2022	BUY	$37.92 - $63.74 $23,131 - $38,881	610 Added 5.95%	10,862 $414,000
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $475,001 - $621,225	-9,900 Reduced 49.13%	10,252 $559,000
Q1 2022 May 12, 2022	BUY	$49.85 - $96.11 $34,994 - $67,469	702 Added 3.61%	20,152 $1.26 Million
Q4 2021 Feb 10, 2022	BUY	$77.3 - $105.0 $46,843 - $63,630	606 Added 3.22%	19,450 $1.96 Million
Q3 2021 Nov 10, 2021	BUY	$74.87 - $110.87 $1.41 Million - $2.09 Million	18,844 New	18,844 $1.7 Million

Others Institutions Holding FLGT

# of Institutions

200

Shares Held

16M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $534M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account